Back

Cost-effectiveness of statin therapy for primary prevention of cardiovascular disease based on different LDL-C targets: a modelling study

30 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Perspectives in public health and cardiovascular diseases (3) Health Economics ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Qiuping Liu

Beijing (China)

4 More presentations in this session

Presentation thumbnail
Rethinking prevention: why mental health should be at the heart of cardiovascular screening programs
Doctor J. Flores Soler (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Bone mineral density and cardiovascular diseases: a two-sample mendelian randomisation study
Doctor D. Condurache (London, GB)
Abstract Slides Video
Presentation thumbnail
Costs of the initial 24-hour emergency room management of heart failure in a tertiary government hospital in the Philippines
Mr J. Joson (Manila, PH)
Abstract Slides Video
Presentation thumbnail
Mortality and hospitalisation costs due to acute myocardial infarction associated with systemic arterial hypertension in brazil from 2010 to 2019
Mr M. Dutra (Manaus, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Perspectives in public health and cardiovascular diseases (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Early lowering of LDL-C is a more cost-effective strategy than lowering LDL-C later in life: a cost-effectiveness analysis using Mendelian Randomisation
thumbnail
Congress Session
Disparities: insights into socioeconomic factors and cardiovascular health
thumbnail
Congress Session
Changing face of lipid-lowering therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources